Article
Economic Analysis of Exclusionary EGFR Test Versus Up-Front NGS for Lung Adenocarcinoma in High EGFR Mutation Prevalence Areas.
Journal of the National Comprehensive Cancer Network : JNCCN - 6 Apr 2022
Yang Szu-Chun, Yeh Yi-Chen, Chen Yi-Lin, Chiu Chao-Hua
Abstract excerpt
BACKGROUND: This study sought to determine whether exclusionary EGFR mutation testing followed by next-generation sequencing (NGS) is a cost-efficient and timely strategy in areas with high prevalence rates of EGFR mutation. METHODS: We developed a decision tree model to compare exclusionary EGFR testing followed by NGS and up-front NGS. Patients entered the model upon diagnosis of metastatic lung adenocarcinoma....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.